MGX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $13,025,000.00
Insider Selling (Last 12 Months): $0.00

Metagenomi Insider Trading History Chart

This chart shows the insider buying and selling history at Metagenomi by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Metagenomi Share Price & Price History

Current Price: $6.89
Price Change: Price Increase of +0.2 (2.99%)
As of 05/21/2024 11:14 AM ET

This chart shows the closing price history over time for MGX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Metagenomi Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/13/2024Holdings A/S NovoMajor ShareholderBuy800,000$15.00$12,000,000.001,739,175View SEC Filing Icon  
2/9/2024Holdings A/S NovoMajor ShareholderBuy100,000$10.25$1,025,000.00100,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Metagenomi (NASDAQ:MGX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MGX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Metagenomi Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024RA Capital Management L.P.1,744,415$18.40M0.2%N/A4.657%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.300,000$3.17M0.1%N/A0.801%Search for SEC Filing on Google Icon
5/15/2024Hhlr Advisors LTD.777,768$8.21M0.2%N/A2.076%Search for SEC Filing on Google Icon
5/15/2024Altitude Crest Partners Inc.133,333$1.41M0.6%N/A0.356%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.179,547$1.89M0.0%N/A0.479%Search for SEC Filing on Google Icon
5/10/2024Resolute Advisors LLC10,000$0.11M0.0%N/A0.027%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Metagenomi logo
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California.
Read More on Metagenomi

Today's Range

Now: $6.89
Low: $6.64
High: $7.15

50 Day Range

MA: $8.84
Low: $6.17
High: $12.00

52 Week Range

Now: $6.89
Low: $5.50
High: $12.74

Volume

5,924 shs

Average Volume

158,962 shs

Market Capitalization

$258.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Metagenomi?

Metagenomi's top insider shareholders include:
  1. Holdings A/S Novo (Major Shareholder)
Learn More about top insider investors at Metagenomi.

Who are the major institutional investors of Metagenomi?

Metagenomi's top institutional shareholders include:
  1. RA Capital Management L.P. — 4.66%
  2. Hhlr Advisors LTD. — 2.08%
  3. Artal Group S.A. — 0.80%
  4. Vanguard Group Inc. — 0.48%
  5. Altitude Crest Partners Inc. — 0.36%
  6. Resolute Advisors LLC — 0.03%
Learn More about top institutional investors of Metagenomi stock.

Which major investors are buying Metagenomi stock?

Within the last quarter, MGX stock was acquired by institutional investors including:
  1. RA Capital Management L.P.
  2. Hhlr Advisors LTD.
  3. Artal Group S.A.
  4. Vanguard Group Inc.
  5. Altitude Crest Partners Inc.
  6. Resolute Advisors LLC